| Epidemiology and healthcare utilization in patients with gastroparesis: a systematic review S Dilmaghani, T Zheng, M Camilleri Clinical Gastroenterology and Hepatology 21 (9), 2239-2251. e2, 2023 | 17 | 2023 |
| Pharmacologic management of obesity‐updates on approved medications, indications and risks C Lupianez‐Merly, S Dilmaghani, K Vosoughi, M Camilleri Alimentary Pharmacology & Therapeutics 59 (4), 475-491, 2024 | 16 | 2024 |
| Severity of dysphagia is associated with hospitalizations and mortality in patients with Parkinson’s disease S Dilmaghani, J Atieh, L Khanna, EA Hosfield, M Camilleri, DA Katzka Neurogastroenterology & Motility 34 (6), e14280, 2022 | 14 | 2022 |
| A randomized, controlled trial of efficacy and safety of cannabidiol in idiopathic and diabetic gastroparesis T Zheng, J BouSaba, A Taylor, S Dilmaghani, I Busciglio, P Carlson, ... Clinical Gastroenterology and Hepatology 21 (13), 3405-3414. e4, 2023 | 13 | 2023 |
| Effects of FGF19 analogue aldafermin in patients with bile acid diarrhea: a randomized, placebo-control trial J BouSaba, M Torres, S Dilmaghani, WS Harmsen, L Ling, M Camilleri Gastroenterology 165 (2), 499-501. e4, 2023 | 8 | 2023 |
| A North American perspective on the ESNM consensus statement on gastroparesis M Camilleri, S Dilmaghani, K Vosoughi, T Zheng Neurogastroenterology and motility: the official journal of the European …, 2021 | 8 | 2021 |
| Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review M Camilleri, S Dilmaghani Pharmacology & Therapeutics 245, 108400, 2023 | 7 | 2023 |
| Prevalence and variations in gastric emptying delay in response to GLP-1 receptor agonist liraglutide M Camilleri, P Carlson, S Dilmaghani Obesity 32 (2), 232-233, 2024 | 6 | 2024 |
| Optimal measurement of gastric emptying of solids in gastroparesis or functional dyspepsia: evidence to establish standard test M Camilleri, T Zheng, K Vosoughi, C Lupianez-Merly, D Eckert, I Busciglio, ... Gut 72 (12), 2241-2249, 2023 | 6 | 2023 |
| Factors associated with successful weight loss after liraglutide treatment for obesity W Sannaa, S Dilmaghani, J BouSaba, D Maselli, J Atieh, D Eckert, ... Diabetes, Obesity and Metabolism 25 (2), 377-386, 2023 | 6 | 2023 |
| Effect of rapid colonic transit on stool microbiome and short-chain fatty acids in diarrhoea-predominant irritable bowel syndrome J BouSaba, T Zheng, S Dilmaghani, S Johnson, J Chen, M Camilleri Gut 73 (2), 375-376, 2024 | 4 | 2024 |
| Risk factor profiles can distinguish esophageal adenocarcinoma from Barrett's esophagus T Sawas, S Dilmaghani, L Dhaliwal, KK Wang, PG Iyer, DA Katzka Official journal of the American College of Gastroenterology| ACG 116 (1 …, 2021 | 4 | 2021 |
| Treatment of irritable bowel syndrome using fecal microbiota transplantation: a step forward? M Camilleri, S Dilmaghani Gastroenterology 163 (4), 815-817, 2022 | 3 | 2022 |
| Epidemiology of gastroparesis: important answers and still more questions S Dilmaghani, M Camilleri Gut 70 (4), 631-632, 2021 | 3 | 2021 |
| Recent developments in diagnosing bile acid diarrhea C Lupianez-Merly, S Dilmaghani, M Camilleri Expert Review of Gastroenterology & Hepatology 17 (12), 1185-1195, 2023 | 2 | 2023 |
| Role of Artificial Intelligence in Colonoscopy: A Literature Review of the Past, Present, and Future Directions S Dilmaghani, N Coelho-Prabhu Techniques and Innovations in Gastrointestinal Endoscopy 25 (4), 399-412, 2023 | 2 | 2023 |
| Acute Esophageal Necrosis Presenting as Acute Blood Loss Anemia K Stanko, S Dilmaghani, A Storm Mayo Clinic Proceedings 98 (1), 21-22, 2023 | 2 | 2023 |
| 34-Year-Old Woman With Human Immunodeficiency Virus and Chronic Diarrhea BH Fortes, S Dilmaghani, SM Ryan Mayo Clinic Proceedings 96 (9), 2474-2479, 2021 | 2 | 2021 |
| Colon volume by computed tomography and Scintigraphic colonic transit in constipated patients with or without redundant colon S Dilmaghani, C Lupianez-Merly, J Fetzer, J BouSaba, H Halawi, ... Clinical Gastroenterology and Hepatology, 2024 | 1 | 2024 |
| FECAL URGENCY ASSOCIATED WITH POOR QUALITY OF LIFE IN QUIESCENT IBD: A CROSS-SECTIONAL STUDY OF SPARC IBD COHORT K Dunleavy, S Dilmaghani, T Fehlmann, L Raffals, V Chedid Gastroenterology 166 (3), S34-S35, 2024 | 1 | 2024 |
